✦ LIBER ✦

Bladder perforation in a patient with recurrent epithelial ovarian cancer after treatment with bevacizumab

✍ Scribed by Nisha Bansal; Mitchell Hoffman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Which factors predict bowel complication

✍ D.L. Richardson; F.J. Backes; J.D. Hurt; L.G. Seamon; L.J. Copeland; J.M. Fowler 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Bevacizumab plus cyclophosphamide in hea

✍ Justin C. Chura; Kelin Van Iseghem; Levi S. Downs Jr.; Linda F. Carson; Patricia 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Secondary leukemia after treatment with

✍ H.T. SEE; D.A. THOMAS; C. BUESO-RAMOS; J. KAVANAGH 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

Incidence and management of bevacizumab-

✍ John P. Diaz; William P. Tew; Oliver Zivanovic; Jason Konner; Paul J. Sabbatini; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 202 KB

Pulmonary hypertension in two patients t

✍ Margaret Liotta; Peter G. Rose; Pedro F. Escobar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Feasibility of Surgery After Systemic Tr

✍ Jalid Sehouli; G. Papanikolaou; E.-I. Braicu; K. Pietzner; P. Neuhaus; C. Fotopo 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 236 KB